Clinical Trials on 合规,耐心 in China
总计360个结果
-
Hospital of Stomatology, Wuhan University招聘中
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated To Inner Mongolia...招聘中
-
Guangzhou University of Traditional Chinese MedicineChinese University of Hong Kong未知
-
Shanghai Tong Ren Hospital招聘中
-
The 458 Hospital of Chinese PLAGuangzhou Baidi Biotechnology Co., Ltd; Guangzhou Pharmaceucal Company Limited未知
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
First Hospital of Zhangjiakou City完全的
-
Shanghai Zhongshan HospitalFudan University; Amoy Diagnostics Co., LTD尚未招聘
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
Fujian Medical University招聘中
-
Second Affiliated Hospital, School of Medicine,...未知
-
Huashan Hospital招聘中
-
The First Affiliated Hospital of Guangzhou Medical...完全的
-
Fifth Affiliated Hospital, Sun Yat-Sen University主动,不招人Patients With Nasopharyngeal Carcinoma中国
-
Hui Lin未知Lung Adenocarcinoma Patients With Postoperative in pN2中国
-
Xiyuan Hospital of China Academy of Chinese Medical...未知
-
Second Affiliated Hospital, School of Medicine,...主动,不招人
-
Centers for Disease Control and Prevention完全的
-
Beijing Anzhen Hospital招聘中Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease中国
-
Peking Union Medical College Hospital未知
-
The Third Affiliated Hospital of Guangzhou Medical...招聘中
-
Abbott完全的HIV-1 Patients捷克共和国, 乔治亚州, 以色列, 拉脱维亚, 立陶宛, 波兰, 罗马尼亚, 俄罗斯联邦, 塞尔维亚, 斯洛伐克, 斯洛文尼亚, 乌克兰
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘绝经前乳腺癌 | 激素受体阳性乳腺癌 | 中高危乳腺癌患者 | 卵巢功能抑制联合芳香化酶抑制剂或他莫昔芬或托瑞美芬中国
-
Wanbangde Pharmaceutical Group Co., LTDSecond Affiliated Hospital, School of Medicine, Zhejiang University尚未招聘
-
University of OxfordBeijing Normal University; Beijing Stars and Rain Education Institute for Autism完全的
-
Samsung Medical Center完全的弥漫性大 B 细胞淋巴瘤或滤泡性淋巴瘤患者 | 接受 Rituximab-CHOP 或 Rituximab-CVP 治疗的患者大韩民国, 马来西亚, 新加坡, 中国
-
Harbin Medical University主动,不招人病理证实的分化型甲状腺癌 | 所有患者均处于初始治疗阶段 | 认知和沟通能力正常,能够阅读和理解中文问卷 | 使用智能手机的能力 | 自愿参与研究并签署知情同意书中国
-
Lai Wei主动,不招人评估塞来昔布加 Nucleos(t)Ide 类似物在接受 Nucleos(t)Ide 治疗的慢性乙型肝炎患者中的安全性和有效性中国